WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO) announced AI utilization plans with OpenAI in a collaboration intended to improve drug development. As part of this collaboration, Thermo Fisher is embedding Open AI APIs into areas of its business that range from product development, service delivery, customer engagement and operational efficiency. The collaboration will: […]




